Pharma Starts a Feedback Loop
Billions are on the table for those who can break out of the mind rubble This is a guest post […]
Billions are on the table for those who can break out of the mind rubble This is a guest post […]
What is Data Exclusivity? In 1984, the USA was the first country to give legal sanctity to data exclusivity via
Patent linkage refers to the relationship between the market approval of a generic drug and the patent status of its
Patent linkage: Balancing patent protection and generic entry Read Post »
What are generic drugs? A generic drug is an identical, or bioequivalent, version of a branded drug made by another
Are Generic Drugs Less Safe than their Branded Equivalents? Read Post »
… the very first official thing I did, in my administration … was to start a patent office; for I
Generic drugs present an opportunity for drug companies to generate substantial revenues. But where do companies find the best return
Finding Generic Drug Entry Opportunities in Emerging Markets Read Post »
This is a guest post from Robert Yapundich, MD and Gregory Schimizzi, MD. Dr. Yapundich is a practicing neurologist in
Biosimilar Naming: Distinguishable or Disingenuous? Read Post »
Thank you for your interest in submitting a guest article! Submit your guest article here DrugPatentWatch is interested in sharing
Hermann A. M. Mucke*, H. M. Pharma Consultancy, Wien, Austria A Multimodal Approach to the Re-development of Drugs Drug repositioning—the
Drug Repositioning in the Mirror of Patenting: Surveying and Mining Uncharted Territory Read Post »